$CRNT Balance Sheet | Understand Stock

$CRNT

$2.17 +$0.07 (3.33%) Live

$CRNT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q4 FY2013 As of Dec 31, 2013	Q4 FY2012 As of Dec 31, 2012	Q4 FY2011 As of Dec 31, 2011
Current assets:
Cash and cash equivalents
Short-term bank deposits
Marketable securities
Trade receivables, net of allowance for credit losses of $14,060 and $13,796 at December 31, 2025 and 2024, respectively
Inventories
Other accounts receivable and prepaid expenses
Deferred tax assets, net
Total current assets

Non-current assets:
Marketable securities
Long-term bank deposits
Trade receivables (net of allowance for credit losses of $ 0 and $ 1,117 at December 31, 2020 and 2021, respectively)
Deferred tax assets
Trade receivables (net of allowance for credit losses of $ 1,117 and $ 0 at December 31, 2021 and 2022, respectively)
Severance pay and pension fund
Property and equipment, net
Operating lease right-of-use assets
Intangible assets, net
Goodwill
Other non-current assets
Total non-current assets

Total assets
Liabilities and shareholders’ equity
Current Liabilities:
Trade payables
Deferred revenues
Short-term loans
Current maturities of long-term loan
Current lease liabilities
Other accounts payable and accrued expenses
Total current liabilities

Non-current liabilities:
Long-term loan, net of current maturities
Deferred tax liability
Accrued severance pay and pensions
Deferred revenues
Operating lease liabilities
Other long-term payables
Total non-current liabilities

Shareholders’ Equity:
Share capital - Ordinary shares of NIS 0.01 par value – Authorized: 240,000,000 and 240,000,000 shares on December 31, 2025 and 2024 respectively; Issued: 94,110,803 and 91,874,448 shares on December 31, 2025 and 2024, respectively; Outstanding: 90,629,280 and 88,392,925 shares on December 31, 2025 and 2024, respectively
Additional paid-in capital
Treasury shares at cost – 3,481,523 ordinary shares on December 31, 2025 and 2024
Accumulated other comprehensive loss
Accumulated deficit
Total shareholders' equity
Total liabilities and shareholders' equity

Comments